The use of adjuvant high-dose-rate breast brachytherapy in patients with collagen vascular disease: A collaborative experience

Women with CVD have a toxicity and cosmesis profile consistent with other APBI series. Although confirmatory data is needed, it may not be necessary to exclude these patients from clinical trials of APBI.